A detailed history of High Tower Advisors, LLC transactions in Lemaitre Vascular Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 5,471 shares of LMAT stock, worth $507,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,471
Previous 5,933 7.79%
Holding current value
$507,435
Previous $488,000 4.1%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$80.3 - $92.89 $37,098 - $42,915
-462 Reduced 7.79%
5,471 $508,000
Q2 2024

Aug 13, 2024

SELL
$62.62 - $83.59 $626 - $835
-10 Reduced 0.17%
5,933 $488,000
Q1 2024

May 06, 2024

SELL
$54.0 - $71.06 $217,026 - $285,590
-4,019 Reduced 40.34%
5,943 $394,000
Q4 2023

Feb 12, 2024

BUY
$45.37 - $58.41 $9,936 - $12,791
219 Added 2.25%
9,962 $565,000
Q3 2023

Nov 08, 2023

BUY
$53.45 - $67.01 $520,763 - $652,878
9,743 New
9,743 $530,000

Others Institutions Holding LMAT

About LEMAITRE VASCULAR INC


  • Ticker LMAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 21,962,900
  • Market Cap $2.04B
  • Description
  • LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that tem...
More about LMAT
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.